Cambridge researchers play key role in evidence leading to approval of new treatment for hereditary blindness
On Aug. 7, 2025, The National Institute for Health and Care Excellence (NICE) has today announced the approval…
-
-
COVID-19 variant vaccine trial began at KPWHRI
On Apr. 1, 2021, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that an investigational vaccine designed to…
